# Optimal Management of HIV Infected Adults at Risk for Kidney Complications in Nigeria

> **NCT03201939** · PHASE2 · TERMINATED · sponsor: **Vanderbilt University Medical Center** · enrollment: 66 (actual)

## Conditions studied

- HIV/AIDS
- Albuminuria
- Kidney Diseases
- Genetic Predisposition

## Interventions

- **DRUG:** Lisinopril
- **OTHER:** Placebo Oral Tablet

## Key facts

- **NCT ID:** NCT03201939
- **Lead sponsor:** Vanderbilt University Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2021-04-01
- **Primary completion:** 2021-11-30
- **Final completion:** 2025-02-01
- **Target enrollment:** 66 (ACTUAL)
- **Why stopped:** DSMB recommendations, laboratory quality control (QC) issues. All lab Q/C issues addressed; DSMB approved study re-opening, but due to length of time required to address lab QC issues, insufficient follow-up time was available to complete study.
- **Last updated:** 2025-06-26

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03201939

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03201939, "Optimal Management of HIV Infected Adults at Risk for Kidney Complications in Nigeria". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03201939. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*